Analysis of Cisatracurium Consumption in Balanced Anesthesia With 1% Sevoflurane, and With Only Sevoflurane, Using a Closed-loop Computer Controlled System Infusion.


The aim in this study was to quantify the difference in cisatracurium and sufentanil consumption, and its recovery period, when patients are under balanced general anesthesia with 1% sevoflurane and patients under only sevoflurane general anesthesia, using a closed loop computer control infusion. Investigators further investigated this effect on its recovery period and sufentanyl consumption.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 2012

Detailed Description

156 patients of American Society of Anesthesiologists (ASA) physical status I and II were assigned to three groups. The patients were all on schedule for elective general surgery under general anesthesia with duration of at two to four hours. All patients were induced with Etomidate (0.2mg/kg), Midazolam (0.05-0.1mg/kg), Sufentanil (0.3-0.5µg/kg) and a bolus dose of Cisatracurium (0.15mg/kg). Patients were aged between 20 and 65. The maintenance of anesthesia in each group varies as follows: Patients in Group 1 were all maintained with Total Intravenous Anesthesia, Group 2 with Sevoflurane at 1% and propofol infusion, Group 3 with only sevoflurane. Muscle paralysis is maintained using a closed-loop computer gated infusion of Cisatracurium which kept T1 <1% by giving increasing the infusion rate intra-operatively when required. Analgesia was maintained by intermittent bolus dose of 10-20 µg of Sufentanil.


  • Drug: 1% Sevoflurane
    • In this group of patients, the maintenance of anesthesia is done by 1% sevoflurane + propofol infusion. Propofol infusion is adjusted according to the Bispectral Index.
  • Drug: Propofol
    • In this group the maintenance of anesthesia is maintained by only propofol infusion.
  • Drug: Sevoflurane
    • In this group only sevoflurane was used for maintenance of anesthesia. the dose of sevoflurane is adjusted to maintain Bispectral Index within 45 and 55.

Arms, Groups and Cohorts

  • Sham Comparator: Total Intravenous Anesthesia
    • Only propofol infusion is used for maintenance of anesthesia keeping Bispectral Index (BIS) between 45-55.
  • Active Comparator: 1% Sevoflurane
    • 1% Sevoflurane with propofol infusion is used for maintenance. BIS is kept between 45-55 by adjusting propofol infusion.
  • Active Comparator: Sevoflurane
    • Only Sevoflurane is used for maintenance keeping BIS between 45-55

Clinical Trial Outcome Measures

Primary Measures

  • Cisatracurium consumption rate.
    • Time Frame: At the time of surgery.
    • Measurements were done intraoperatively. Investigators obtained data from the closed loop computer system, from which the intra-operative consumption of cisatracurium were obtained from each patient. Data were collected only during surgery. Each patient had different cisatracurium consumption rate, and the mean consumption rate of the patients within the same group were calculated, and compared with the means from the other groups.

Secondary Measures

  • Analysis of Means of Recovery Index.
    • Time Frame: 30 minutes post operative.
    • Recovery Index was the time for the Train-Of-Four ratio (TOF) to increase from 25% to 75%. The TOF ratio was recorded every minute till it reached 90%. Time taken for each patient was from 5 to 25 minutes. Investigators compared the average recovery index of patients from each group.

Participating in This Clinical Trial

Inclusion Criteria

  • Patients aged 20 and 65. – Patients with ASA 1 and 2. – Patients for elective abdominal general surgery Exclusion Criteria:

  • Patients with the following diseases are excluded, since they are known to cause generalized neuromuscular weakness: Neuromuscular junction disorders (e.g.. myasthenia gravis) Myopathies (e.g.. Muscular Dystrophies, Rhabdomyolysis) Peripheral Neuropathies (e.g. Guillain-Barre Syndrome, Polyneuropathies) Encephalopathies (Septic and Toxic-metabolic Encephalopathy) Patients with renal and liver diseases. – Patients who are sent intubated to ICU after surgery. – Patients refusal

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Tianjin Medical University General Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Joomye Shehzaad, Joomye Shehzaad M.D. – Tianjin Medical University General Hospital
  • Overall Official(s)
    • Shehzaad Joomye, M.D., Principal Investigator, Tianjin Medical University General Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.